Benzinga - by Lisa Levin, Benzinga Editor.
U.S. stock futures traded lower this morning on Tuesday. Here are some big stocks recording losses in today’s pre-market trading session.
- Ventyx Biosciences, Inc. (NASDAQ: VTYX) shares tumbled 74% to $3.66 in pre-market trading after the company announced efficacy results from the Phase 2 trial of VTX958 in plaque psoriasis did not meet the internal target to support further development of VTX958 in psoriasis.
- Alto Ingredients, Inc. (NASDAQ: ALTO) shares declined 52.4% to $2.34 in pre-market trading after the company reported mixed third-quarter financial results.
- Coherus BioSciences, Inc. (NASDAQ: CHRS) shares dipped 18.9% to $2.87 in pre-market trading after the company reported mixed third-quarter financial results.
- Ameresco, Inc. (NASDAQ: AMRC) shares declined 18.4% to $21.70 in pre-market trading following downbeat third-quarter results.
- Aura Biosciences, Inc. (NASDAQ: AURA) declined 15.5% to $9.30 in pre-market. Aura Biosciences priced its public offering of 11 million common shares at $9 per share.
- Clover Health Investments, Corp. (NASDAQ: CLOV) shares dropped 15.1% to $0.96 in pre-market trading following weak quarterly sales.
- Sanmina Corporation (NASDAQ: SANM) shares fell 12% to $46.50 in pre-market trading after the company reported worse-than-expected fourth-quarter financial results.
- Alpine Immune Sciences, Inc. (NASDAQ: ALPN) fell 9.4% to $12.80 in pre-market trading. Alpine Immune Sciences priced its $150 million public offering of 8.8 million common shares at $12.50 per share.
- ADTRAN Holdings, Inc. (NASDAQ: ADTN) shares fell 9.1% to $6.66 in pre-market trading following a wider-than-expected quarterly loss.
- Under Armour, Inc. (NYSE: UA) declined 8.3% to $6.11 in pre-market trading.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
Don’t forget to check out our premarket coverage here
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.